This inventor holds 1 USPTO granted patent. Top assignees: Leiden University Medical Center, Stichting Katholieke Universiteit. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 15 
1 out of 64 
Years Active: 2009
Title: Andrew Paul Waters: Innovator in Malaria Vaccine Development
Introduction
Andrew Paul Waters is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of medical research, particularly in the development of vaccines against malaria. His innovative work focuses on creating new mutants that can provide long-lasting protection against malaria infections.
Latest Patents
Andrew Paul Waters holds a patent related to the production of new mutants that are defective in the expression of the protein P36p. These mutants are unable to cause malaria, yet they can be utilized as a vaccine, offering long-lasting protection against infections with wild-type malaria.
Career Highlights
Throughout his career, Waters has worked with esteemed institutions such as Leiden University Medical Center and the Catholic University of Nijmegen. His research has been pivotal in advancing the understanding of malaria and developing potential vaccines.
Collaborations
He has collaborated with notable colleagues, including Christofel Jan Janse and Melissa Ruth Van Dijk, contributing to the collective effort in malaria research and vaccine development.
Conclusion
Andrew Paul Waters is a key figure in the fight against malaria, with his innovative approaches paving the way for future advancements in vaccine technology. His work exemplifies the importance of research in combating infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile